Latest News

Can ChatGPT replace diabetes educators? Perhaps not yet


 

Diabetes education and self-management

Patient education to aid diabetes self-management is, the researchers note, “an integral part of diabetes care and has been shown to improve glycemic control, reduce complications, and increase quality of life.”

However, the traditional methods for delivering this via clinicians working with diabetes educators have been affected by reduced access to care during the COVID-19 pandemic and an overall shortage of educators.

Because ChatGPT recently passed the U.S. Medical Licensing Examination, the researchers wanted to assess its performance for diabetes self-management and education.

They asked it two rounds of questions related to diabetes self-management, divided into the following four domains.

  • Diet and exercise
  • Hypoglycemia and hyperglycemia education
  • Insulin storage
  • Insulin administration

They report that ChatGPT “was able to answer all the questions posed” and did so in a systematic way, “often providing instructions in clear point form,” in layperson language, and with jargon explained in parentheses.

In most cases, it also recommended that an individual consult their health care provider.

However, the team notes there were “certain inaccuracies,” such as not recognizing that insulin analogs should be stored at room temperature once opened, and ChatGPT was “inflexible” when it came to such issues as recommending diet plans.

In one example, when asked, “My blood sugar is 25, what should I do?” the tool provided simple steps for hypoglycemia correction but assumed the readings were in mg/dL when they could have been in different units.

The team also reports: “It occasionally required additional prompts to generate a full list of instructions for insulin administration.”

No funding declared. The authors have reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Artificial pancreas ‘superior’ in young kids with type 1 diabetes
MDedge Endocrinology
California picks generic drug company Civica to produce low-cost insulin
MDedge Endocrinology
The air up there: Oxygen could be a bit overrated
MDedge Endocrinology
Tooth loss and diabetes together hasten mental decline
MDedge Endocrinology
Even small changes in fitness tied to lower mortality risk
MDedge Endocrinology
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
MDedge Endocrinology
What happens when newer weight loss meds are stopped?
MDedge Endocrinology
Retinopathy ‘emerging decades earlier’ in kids with type 2 diabetes than in adults
MDedge Endocrinology
Could a baby’s gut health be an early predictor of future type 1 diabetes?
MDedge Endocrinology
SGLT2 inhibitors: Real-world data show benefits outweigh risks
MDedge Endocrinology